Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

43,361.00ZAc
9:11am EST
Change (% chg)

-939.00c (-2.12%)
Prev Close
44,300.00c
Open
44,868.00c
Day's High
44,868.00c
Day's Low
43,160.00c
Volume
1,061,880
Avg. Vol
708,609
52-wk High
44,868.00c
52-wk Low
23,626.00c

APNJ.J

Chart for APNJ.J

About

Aspen Pharmacare Holdings Limited is a South Africa-based pharmaceutical company. The Company through its subsidiaries manufactures branded and generic pharmaceutical products as well as infant milk nutritionals and consumer healthcare products in selected territories, operating primarily in the healthcare industry. The Company... (more)

Overall

Beta: 0.52
Market Cap(Mil.): R202,162.41
Shares Outstanding(Mil.): 456.35
Dividend: 188.00
Yield (%): 0.42

Financials

  APNJ.J Industry Sector
P/E (TTM): 40.38 39.77 40.41
EPS (TTM): 10.97 -- --
ROI: 10.11 19.02 18.28
ROE: 19.38 19.82 19.19
Search Stocks

BRIEF-Aspen Pharmacare buys rights to Novartis anti-coagulant Mono-Embolex

* Acquisition of rights to an anti-coagulant product from Novartis

23 Jan 2015

Aspen, Cipla win share of $860 million South Africa AIDS drug tender

JOHANNESBURG - South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising.

24 Dec 2014

BRIEF-Aspen provides update on Fondaparinux products in the US

* further announcement regarding the disposal of rights to commercialise fondaparinux products in the us

26 Sep 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Sadif Analytics Prime
$10.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks